Published in Biol Psychiatry on May 01, 1999
Gene expression profile of the nucleus accumbens of human cocaine abusers: evidence for dysregulation of myelin. J Neurochem (2004) 1.82
Brain macrostructural and microstructural abnormalities in cocaine dependence. Drug Alcohol Depend (2007) 1.59
Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology (2006) 1.45
Cocaine-induced cortical microischemia in the rodent brain: clinical implications. Mol Psychiatry (2011) 1.31
Gene expression profiling in the brains of human cocaine abusers. Addict Biol (2005) 1.07
Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants? Neurosci Biobehav Rev (2012) 1.01
Assessing white matter integrity as a function of abstinence duration in former cocaine-dependent individuals. Drug Alcohol Depend (2010) 0.98
BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION. Adolesc Psychiatry (2005) 0.86
Intravenous tissue plasminogen activator in patients with cocaine-associated acute ischemic stroke. Stroke (2009) 0.86
Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity? World J Biol Psychiatry (2013) 0.81
Smaller regional gray matter volume in homeless african american cocaine-dependent men: a preliminary report. Open Neuroimag J (2011) 0.79
EEG and cerebral blood flow velocity abnormalities in chronic cocaine users. Clin EEG Neurosci (2009) 0.75
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"? Schizophr Bull (2000) 9.62
Disability income, cocaine use, and repeated hospitalization among schizophrenic cocaine abusers--a government-sponsored revolving door? N Engl J Med (1995) 4.77
Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia. Am J Psychiatry (1998) 4.31
Informed consent: assessment of comprehension. Am J Psychiatry (1998) 3.74
Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res (1998) 3.69
Cost comparison: a desflurane- versus a propofol-based general anesthetic technique. Anesth Analg (1994) 3.09
Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. Arch Gen Psychiatry (2001) 2.91
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful study. Acta Psychiatr Scand (2007) 2.89
Implications of therapist effects for the design and analysis of comparative studies of psychotherapies. J Consult Clin Psychol (1991) 2.49
Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia. Am J Psychiatry (2001) 2.47
Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil (2010) 2.47
Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry (1996) 2.14
Metabolites formed during anaerobic transformation of toluene and o-xylene and their proposed relationship to the initial steps of toluene mineralization. Appl Environ Microbiol (1992) 2.10
Hyperalgesic responses in methadone maintenance patients. Pain (2001) 2.09
Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress. Schizophr Bull (1992) 2.08
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant (2010) 2.00
Funding Canada's health care system: a tax-based alternative to privatization. CMAJ (1998) 1.92
Molecular model for elastin structure and function. Nature (1974) 1.91
Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia: a multicenter experience. Ophthalmology (1997) 1.85
Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature. Am J Psychiatry (2001) 1.85
Cognitive impairment in individuals currently using methamphetamine. Am J Addict (2000) 1.78
Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug Alcohol Depend (2001) 1.77
Botulinum toxin type a for dysthyroid upper eyelid retraction. Ophthal Plast Reconstr Surg (2004) 1.77
Sexual HIV risk among gay and bisexual male methamphetamine abusers. J Subst Abuse Treat (1997) 1.70
Absence of evidence for bornavirus infection in schizophrenia, bipolar disorder and major depressive disorder. Mol Psychiatry (2012) 1.59
Functional components of basic fibroblast growth factor signaling that inhibit lung elastin gene expression. Am J Physiol Lung Cell Mol Physiol (2001) 1.58
Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry (2006) 1.58
Family factors and the course of bipolar affective disorder. Arch Gen Psychiatry (1988) 1.57
Diagnosing addictive disease in chronic pain patients. Psychosomatics (1997) 1.55
Patients' perceptions of family emotional climate and outcome in schizophrenia. Br J Psychiatry (1993) 1.55
Contingency management for tobacco smoking in methadone-maintained opiate addicts. Addict Behav (1996) 1.54
Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. Arch Gen Psychiatry (1998) 1.53
Novel antipsychotics: comparison of weight gain liabilities. J Clin Psychiatry (1999) 1.53
An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol Psychiatry (2000) 1.53
An intensive outpatient approach for cocaine abuse treatment. The Matrix model. J Subst Abuse Treat (1995) 1.51
Differential efficacy of olanzapine for deficit and nondeficit negative symptoms in schizophrenia. Am J Psychiatry (2000) 1.49
Use of disulfiram for alcoholics in methadone maintenance programs. A Veterans Administration Cooperative Study. Arch Gen Psychiatry (1983) 1.47
Backward masking in schizophrenia and mania. II. Specifying the visual channels. Arch Gen Psychiatry (1994) 1.44
LAAM maintenance vs methadone maintenance for heroin dependence. Cochrane Database Syst Rev (2002) 1.43
Plasma levels of fluphenazine in patients receiving fluphenazine decanoate. Relationship to clinical response. Br J Psychiatry (1991) 1.42
In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch Gen Psychiatry (2000) 1.41
Backward masking in schizophrenia and mania. I. Specifying a mechanism. Arch Gen Psychiatry (1994) 1.40
Browlift with botulinum toxin. Dermatol Surg (2000) 1.40
The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay. J Clin Psychiatry (1996) 1.40
The temporal relationship between depressive and psychotic symptoms in recent-onset schizophrenia. Am J Psychiatry (1990) 1.40
Does risperidone improve verbal working memory in treatment-resistant schizophrenia? Am J Psychiatry (1997) 1.39
Addiction medicine. JAMA (1996) 1.38
Statistical guidelines for the Archives of PM&R. New Hampshire-Dartmouth Psychiatric Research Center. Arch Phys Med Rehabil (1995) 1.38
Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn Reson Med (1993) 1.37
Induced sputum to assess airway inflammation: a study of reproducibility. Clin Exp Allergy (1997) 1.35
Methamphetamine and cocaine users: differences in characteristics and treatment retention. J Psychoactive Drugs (2000) 1.35
Substrate induction and metabolite accumulation during anaerobic toluene utilization by the denitrifying strain T1. Appl Environ Microbiol (1993) 1.35
Oltipraz upregulates the nuclear factor (erythroid-derived 2)-like 2 [corrected](NRF2) antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL/6J mice. Diabetologia (2010) 1.33
MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging (1999) 1.31
Isolation and amino acid sequences of tropoelastin peptides. J Biol Chem (1973) 1.29
Reliability of in vivo volume measures of hippocampus and other brain structures using MRI. Magn Reson Imaging (1993) 1.27
Costs and benefits of two doses of fluphenazine. Arch Gen Psychiatry (1984) 1.22
In vivo MR evaluation of age-related increases in brain iron. AJNR Am J Neuroradiol (1994) 1.21
Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine. Pain (2001) 1.21
Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology (2000) 1.20
Targeting of a germ cell-specific type 1 hexokinase lacking a porin-binding domain to the mitochondria as well as to the head and fibrous sheath of murine spermatozoa. Mol Biol Cell (1998) 1.19
Declarative and procedural memory in bipolar disorder. Biol Psychiatry (1999) 1.18
A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend (1995) 1.17
Alcohol increases cigarette smoking: a laboratory demonstration. Addict Behav (1985) 1.17
Backward masking in unmedicated schizophrenic patients in psychotic remission: possible reflection of aberrant cortical oscillation. Am J Psychiatry (1999) 1.17
Immigrant families coping with schizophrenia. Behavioral family intervention v. case management with a low-income Spanish-speaking population. Br J Psychiatry (1995) 1.17
Pain responses in methadone-maintained opioid abusers. J Pain Symptom Manage (2000) 1.17
Translation of chick aortic elastin messenger ribonucleic acid. Comparison to elastin synthesis in chick aorta organ culture. Biochemistry (1980) 1.16
Codon optimization, genetic insulation, and an rtTA reporter improve performance of the tetracycline switch. Transgenic Res (1999) 1.16
A controlled dose comparison of haloperidol in newly admitted schizophrenic patients. Arch Gen Psychiatry (1990) 1.15
RNA splicing in Neurospora mitochondria. Characterization of new nuclear mutants with defects in splicing the mitochondrial large rRNA. Cell (1982) 1.13
Age-related brain volume reductions in amphetamine and cocaine addicts and normal controls: implications for addiction research. Psychiatry Res (2000) 1.13
High affinity saturable uptake of oxidized low density lipoprotein by macrophages from mice lacking the scavenger receptor class A type I/II. J Biol Chem (1997) 1.13
Overdose, suicide attempts and death among a cohort of naltrexone-treated opioid addicts. Drug Alcohol Depend (1997) 1.13
Computer simulation of transposable element evolution: random template and strict master models. J Mol Evol (1996) 1.12
A program for relapse prevention in schizophrenia: a controlled study. Arch Gen Psychiatry (2000) 1.12
Integrating treatments for methamphetamine abuse: a psychosocial perspective. J Addict Dis (1997) 1.11
Assembly of AKAP82, a protein kinase A anchor protein, into the fibrous sheath of mouse sperm. Dev Biol (1997) 1.11
Intracerebroventricular but not intravenous interleukin-1beta induces widespread vascular-mediated leukocyte infiltration and immune signal mRNA expression followed by brain-wide glial activation. Neuroscience (2002) 1.10
The vulnerability/stress model of schizophrenic relapse: a longitudinal study. Acta Psychiatr Scand Suppl (1994) 1.09
Expressed emotion and schizophrenic outcome among Mexican-American families. J Nerv Ment Dis (1987) 1.08
The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal. Medication development issues for opiate addiction. Neuropsychopharmacology (1995) 1.08
Direct orbital manometry in patients with thyroid-associated orbitopathy. Ophthalmology (1999) 1.08
MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn Reson Imaging (1997) 1.08
Allophycocyanin from the filamentous cyanophyte, Phormidium luridum. Biochemistry (1975) 1.07
Monetary reinforcement of abstinence from cocaine among mentally ill patients with cocaine dependence. Psychiatr Serv (1997) 1.07
Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet (1997) 1.07
Relationship between blood pressure and subcortical lesions in healthy elderly people. Stroke (1998) 1.06
Questionnaires of accident and emergency departments: are they reproducible? J Accid Emerg Med (2000) 1.06
Low- and conventional-dose maintenance therapy with fluphenazine decanoate. Two-year outcome. Arch Gen Psychiatry (1987) 1.05